Skip to main content
. 2020 Nov 9;2(2):fcaa192. doi: 10.1093/braincomms/fcaa192

Table 2.

Demographic and clinical characteristics of the cohorts

(a) Validation of subtyping methods in AD dementia patients (sMRI cohort)
HC (Aβ−) AD dementia (Aβ+) P-value
N 70 89
Sex (F,%) 51 39 0.139
Age (years) 75.15 ± 5.22 [62, 89] 74.73 ± 7.72 [57, 88] 0.757
Education (years) 15.66 ± 2.65 [8, 20] 15.16 ± 3.24 [4, 20] 0.402
APOE ε4 carriers (%) 10 74 <0.0001
MMSE 29.04 ± 1.10 [25, 30] 23.48 ± 1.87 [20, 26] <0.0001
Word recall task 2.86 ± 1.17 [0 5.67] 6.24 ± 1.34 [3.33, 9.33] <0.0001
Naming objects and fingers 0.08 ± 0.28 [0, 1] 0.43 ± 0.56 [0, 2] <0.0001
Following commands 0.05 ± 0.23 [0, 1] 0.40 ± 0.63 [0, 3] <0.0001
Constructional praxis 0.41 ± 0.49 [0, 1] 0.91 ± 0.65 [0, 3] <0.0001
Ideational praxis 0.05 ± 0.23 [0, 1] 0.33 ± 0.72 [0, 5] 0.0007
Orientation 0.12 ± 0.37 [0, 2] 2.06 ± 1.61 [0, 7] <0.0001
Word recognition task 2.38 ± 2.24 [0, 12] 6.51 ± 2.88 [1, 2] <0.0001
Recall of test instructions 0 ± 0 [0, 0] 0.31 ± 0.88 [0, 5] 0.0005
Spoken language 0.02 ± 0.16 [0, 1] 0.30 ± 0.64 [0, 3] 0.0006
Word finding difficulty 0.04 ± 0.20 [0, 1] 0.59 ± 0.95 [0, 4] <0.0001
ADAS total score 6.06 ± 2.79 [1.67, 14.33] 18.38 ± 6.26 [8.67, 42.67] <0.0001

(b) Subtyping methods in prodromal AD and AD dementia patients (sMRI-tauPET cohort)

HC (Aβ−) Prodromal AD (Aβ+) AD dementia (Aβ+) P-value

N 200 54 30
Sex (F, %) 59 48 50 0.285
Age (years) 70.45 ± 5.65 [55.8, 89]a 74.09 ± 7.34 [59.4, 90.1]a 77.46 ± 8.27 [55.9, 91.2]a <0.0001
Education (years) 16.90 ± 2.31 [11, 20]a 15.76 ± 2.66 [12, 20]b 15.77 ± 2.57 [12, 20]b 0.002
APOE ε4 carriers (%) 22 61 53 <0.0001
MMSE 29.24 ± 1.05 [23, 30]a 27.48 ± 2.30 [19, 30]a 22.13 ± 4.23 [9, 30]a <0.0001
Word recall task 2.36 ± 1.81 [0 6]a 4.34 ± 1.49 [1, 7]a 6.09 ± 1.61 [3, 10]a <0.0001
Naming objects and fingers 0.03 ± 0.37 [0, 3] 0.04 ± 0.19 [0, 1]b 0.56 ± 0.89 [0, 3]b <0.0001
Following commands 0.06 ± 0.24 [0, 1] 0.22 ± 0.41 [0, 1]b 0.40 ± 0.91 [0, 3]b 0.0011
Constructional praxis 0.33 ± 0.55 [0, 3] 0.48 ± 0.57 [0, 2] 0.72 ± 0.79 [0, 3]b 0.0084
Ideational praxis 0.05 ± 0.38 [0, 5] 0.08 ± 0.34 [0, 2] 0.28 ± 0.54 [0, 2]b <0.0001
Orientation 0.09 ± 0.29 [0, 1]a 0.50 ± 0.73 [0, 3]a 2.8 ± 2.1 [0, 7]a <0.0001
Word recognition task 4.92 ± 1.91 [0, 10]a 5.9 ± 2.77 [0, 12]a 9.28 ± 2.73 [3, 12]a <0.0001
Recall of test instructions 0.005 ± 0.07 [0, 1] 0.14 ± 0.53 [0, 3]b 0.95 ± 1.39 [0, 5]b <0.0001
Spoken language 0.005 ± 0.07 [0, 1]a 0.04 ± 0.19 [0, 1]a 0.44 ± 1.00 [0, 4]a <0.0001
Word finding difficulty 0.04 ± 0.27 [0, 3]a 0.18 ± 0.43 [0, 2]a 0.88 ± 1.05 [0, 3]a <0.0001
ADAS total score 8.08 ± 2.86 [1, 19.33]a 11.98 ± 4.66 [3, 24]a 21.68 ± 7.48 [7, 37]a <0.0001

Data are reported as mean ± standard deviation [minimum, maximum]; Hypothesis testing was performed using the Kruskal–Wallis test for the continuous variables and χ2 test for the nominal variables. Additionally, the Kruskal–Wallis test was performed pairwise between groups in the sMRI-tauPET cohort.

AD = Alzheimer’s disease; ADAS = Alzheimer's Disease Assessment Scale-Cognitive Subscale; APOE = apolipoprotein; Aβ = amyloid-beta; F = female; HC = healthy control; MMSE = mini-mental state examination; PET = positron emission tomography; sMRI = structural MRI.

a

Significantly different from each of the other two groups.

b

Significantly different from HC group only.